在杜申肌力发育不良症中,44号外显子跳转:NS-089/NCNP-02,一种双重准的反感性寡核酸
Naoki Watanabe1, Yuichiro Tone1, Tetsuya Nagata2,3
1Discovery Research Laboratories in Tsukuba, Nippon Shinyaku Co., Ltd, Tsukuba, Ibaraki, Japan.
Molecular therapy. Nucleic acids
|October 19, 2023
概括
一种新型的反感性寡核酸设计有效地跳过了杜申肌肉发育不良细胞和动物模型中的44号外因子. 这种创新的方法显示出开发新的外跳转疗法对杜申肌肉发育不良患者的希望.
科学领域:
- 遗传学和分子生物学
- 生物技术是生物技术.
- 神经学 神经学
背景情况:
- 反感性寡核酸 (ASOs) 通过诱导外显子跳转,为杜申肌肉衰竭 (DMD) 提供治疗策略.
- 目前的ASO疗法通常针对单个连续序列进行表子跳转.
研究的目的:
- 开发和评估一种新型的ASO设计,以改善杜恩肌肉发育不良症的外跳跃活性.
- 特别调查针对44号外子的ASO,该外子适用于大约6%的DMD患者.
主要方法:
- 设计了具有两个连接序列的二胺酸形类寡合体 (PMOs),以同时准44号外中的两个拼接调节器.
- 在实验室中使用患者衍生细胞评估了exon 44跳转效率.
- 在Cynomolgus子中通过静脉注射评估了候选药物的体内疗效 (NS-089/NCNP-02).
主要成果:
- 新型连接序列ASO,NS-089/NCNP-02,与其他测试的寡合体相比,显示出优异的44号外显子跳转活性.
- 在DMD患者细胞中,NS-089/NCNP-02成功诱导了44号外因子跳转,并恢复了双蛋白表达.
- 在Cynomolgus子的体内研究表明,NS-089/NCNP-02有效地诱导了骨和心脏肌肉中的44号外子跳转.
结论:
- NS-089/NCNP-02采用了新的连接序列设计,具有高效的外型跳转能力.
- 这种ASO在杜申肌肉缩症患者中显示出治疗应用的巨大潜力,这些患者容易受到44号外子跳转的影响.
- 这项研究证实了这种创新的ASO设计在体外和体外的有效性.
相关概念视频
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Exon Recombination
3.6K
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon...
Exon shuffling follows “splice frame rules.” Each exon...
3.6K
Long-patch Base Excision Repair
7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K


